|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/00 |
| (11) | Patento numeris | 2563391 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11716402.0 |
| Europos patento paraiškos padavimo data | 2011-04-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/056461 |
| Data | 2011-04-21 |
| (87) | Numeris | WO 2011/134899 |
| Data | 2011-11-03 |
| (30) | Numeris | Data | Šalis |
| 10161181 | 2010-04-27 | EP |
| (72) |
HERTING, Frank, DE
KLEIN, Christian, CH
|
| (73) |
Roche Glycart AG,
Wagistrasse 18, 8952 Schlieren,
CH
|
| (54) | COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR |
| COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR |